other material
confidence high
sentiment neutral
materiality 0.20
Dermata increases ATM offering capacity by $705K; previously sold $3.45M under same program
Dermata Therapeutics, Inc.
- Filed prospectus supplement to increase maximum aggregate offering under ATM by $705,000.
- Prior sales under the June 2024 H.C. Wainwright ATM agreement totaled $3,454,390.
- ATM program covers common stock issuances; legal opinion filed as Exhibit 5.1.
- No change in business fundamentals; routine capital access expansion.